MarketStudyReport.com adds “Global Iodixanol (CAS 92339-11-2) Market Outlook 2016-2021” new report to its research database. The report spread across 121 pages with table and figures in it.
Iodixanol is a contrast agent, sold under the trade name Visipaque; it is also sold as a density gradient medium under the name OptiPrep. Visipaque is commonly used as a contrast agent during coronary angiography. It is the only iso-osmolar contrast agent, with an osmolality of 290 mOsm/kg H2O, the same as blood. It is sold in 2 main concentrations 270 mgI/ml and 320 mgI/ml – hence the name Visipaque 270 or 320. It is sold in single dose units and a large 500ml plastic bottle for multi-dose dispensing.
Browse full table of contents and data tables at https://www.marketstudyreport.com/reports/global-iodixanol-cas-92339-11-2-market-outlook-2016-2021/
This report provides detailed analysis of worldwide markets for Iodixanol (CAS 92339-11-2) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Iodixanol (CAS 92339-11-2) market and further lays out an analysis of the factors influencing the supply/demand for Iodixanol (CAS 92339-11-2), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
The report, report, Global Iodixanol (CAS 92339-11-2) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Iodixanol (CAS 92339-11-2) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Iodixanol (CAS 92339-11-2) market are GE Healthcare (UK), Grupo Juste (Spain), Hovione FarmaCiencia (Portugal), Zhejiang Starry (China), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Iodixanol (CAS 92339-11-2) industry has been provided.
To receive personalized assistance, write to us @ email@example.com with the report title in the subject line along with your questions or call us at +1 866-764-2150